Related Experiment Video
Updated: Oct 17, 2025

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Monoreassortant Rotaviruses of Multiple G Types Are Differentially Neutralized by Sera From Infants Vaccinated With
Julia R Diller1, Maximilian H Carter1, Yuta Kanai2
1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Insights
Rotavirus VP7 influences antibody responses and cell tropism. RotaTeq vaccination elicits broader neutralizing antibody responses than ROTARIX, impacting rotavirus G-type neutralization breadth.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Rotavirus is a major cause of severe diarrheal illness and mortality in children worldwide.
- The rotavirus outer capsid proteins, VP7 (G type) and VP4 (P type), are key targets for neutralizing antibodies.
Purpose of the Study:
- To investigate the role of rotavirus VP7 in eliciting specific neutralizing antibody responses.
- To compare the breadth of antibody responses induced by different rotavirus vaccines.
Main Methods:
- Engineered monoreassortant rotaviruses with specific human VP7 segments.
- Assessed viral replication and neutralization using sera from infants vaccinated with ROTARIX or RotaTeq.
Main Results:
- RotaTeq vaccination induced broader neutralizing antibody responses compared to ROTARIX.
- A single dose of RotaTeq enhanced the G-type neutralization breadth in vaccinated infants.
- Observed cell type-specific variations in infectivity, replication, and neutralization of engineered rotaviruses.
Conclusions:
- Rotavirus VP7 can independently influence viral cell tropism.
- VP7 plays a significant role in the breadth of vaccine-induced neutralizing antibody responses against rotavirus.
Background:
Rotavirus is a leading cause of pediatric diarrheal mortality. The rotavirus outer capsid consists of VP7 and VP4 proteins, which, respectively, determine viral G and P type and are primary targets of neutralizing antibodies.
Methods:
To elucidate VP7-specific neutralizing antibody responses, we engineered monoreassortant rotaviruses each containing a human VP7 segment from a sequenced clinical specimen or a vaccine strain in an identical genetic background. We quantified replication and neutralization of engineered viruses using sera from infants vaccinated with monovalent ROTARIX or multivalent RotaTeq vaccines.
Results:
Immunization with RotaTeq induced broader neutralizing antibody responses than ROTARIX. Inclusion of a single dose of RotaTeq in the schedule enhanced G-type neutralization breadth of vaccinated infant sera. Cell type-specific differences in infectivity, replication, and neutralization were detected for some monoreassortant viruses.
Conclusions:
These findings suggest that rotavirus VP7, independent of VP4, can contribute to cell tropism and the breadth of vaccine-elicited neutralizing antibody responses.
Related Concept Videos
Viral Recombination
Viruses with RNA Genomes

